EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Different underlying aetiologies in patients presenting with ventricular tachycardia fulfilling task force criteria for arrhythmogenic right ventricular cardiomyopathy: initial suspicion based on the 12-lead electrocardiogram

Jarieke C Hoogendoorn iD, Laurens P Bosman iD, Jeroen F van der Heijden, Arthur A Wilde iD, Maarten P van den Berg iD, Sing-Chien Yap iD, J Peter van Tintelen iD, Dennis Dooijes iD, Anneline S J M Te Riele iD, Katja Zeppenfeld iD

Europace · 2025

DOI: 10.1093/europace/euaf136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2025. Verfasst von Jarieke C Hoogendoorn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Willem Einthoven Center for Cardiac Arrhythmia Research and Management (WECAM), Leiden University Medical Center, Albinusdr…. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Electrocardiography, Tachycardia, Ventricular. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Edwards Lifesciences, Biotronik, Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The task force criteria (TFC) for arrhythmogenic right ventricular cardiomyopathy (ARVC) are highly sensitive but lack specificity. Atypical RV involvement (aRVi) may indicate different underlying aetiologies and prognosis, requiring specific therapeutic interventions. We aimed to evaluate the role of the baseline 12-lead ECG for initial suspicion of aRVi.

Methods

From the Netherlands Heart Institute Arrhythmogenic Cardiomyopathy (NHI-ACM) registry, patients were selected who (i) fulfilled TFC for definite ARVC, (ii) presented with sustained ventricular tachycardia (VT), and (iii) underwent genetic testing. The first available ECG after VT was evaluated. PR prolongation ≥220 ms and/or a surface area of the maximum R′-wave in V1–V3 of ≥1.65 mm2 was defined as an aRVi-ECG. Patients with an ARVC-related pathogenic/likely pathogenic variant (P/LP+) were classified as ‘ARVC’. Data of P/LP− were reviewed by an expert panel and classified as either ‘ARVC’ or ‘different aetiology’ based on consensus.

Results

A total of 159 patients were included (122 P/LP+ and 37 P/LP− patients). Nineteen patients had an aRVi-ECG [11 (9%) P/LP+ vs. 8 (22%) P/LP−, P = 0.038]. Of the P/LP− patients, 17 (46%) were classified as ‘different aetiology’ (e.g. myocarditis, ischaemia, sarcoidosis), including all 8 patients with an aRVi-ECG. Among the P/LP+ patients with an aRVi-ECG, 46% carried the p.Arg14del phospholamban pathogenic variant, and 64% died compared to 15 and 19% of P/LP+ patients without an aRVi-ECG, respectively (both P < 0.01).

Conclusion

In P/LP− patients presenting with VT and fulfilling TFC, an aRVi-ECG should raise suspicion for a different underlying aetiology. In P/LP+ patients, an aRVi-ECG may identify those with poor outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmogenic Right Ventricular DysplasiaElectrocardiographyTachycardia, VentricularHumansMaleFemaleMiddle AgedAdultRegistriesNetherlandsPredictive Value of TestsGenetic TestingAction PotentialsHeart Rate

Stichwörter der Autor:innen

Arrhythmogenic right ventricular cardiomyopathyCardiac sarcoidosisElectrocardiogramVentricular tachycardia

Autor:innen und Institutionen

  • Department of Cardiology, Willem Einthoven Center for Cardiac Arrhythmia Research and Management (WECAM), Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
  • Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
  • Department of Cardiology, Haga Ziekenhuis, Den Haag, The Netherlands.
  • Department of Cardiology, Heart Centre, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands.
  • European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart ).

ORCID-Profile: Jarieke C Hoogendoorn, Laurens P Bosman, Arthur A Wilde, Maarten P van den Berg, Sing-Chien Yap, J Peter van Tintelen, Dennis Dooijes, Anneline S J M Te Riele, Katja Zeppenfeld

Förderung

  • Edwards Lifesciences
  • Biotronik
  • Medtronic
  • Boston Scientific
  • Biosense Webster
  • ZonMw
  • Horizon IMPACT

Zitieren

APA

Hoogendoorn, J. C., Bosman, L. P., van der Heijden, J. F., Wilde, A. A., van den Berg, M. P., Yap, S. C., van Tintelen, J. P., Dooijes, D., Te Riele, A. S. J. M., & Zeppenfeld, K. (2025). Different underlying aetiologies in patients presenting with ventricular tachycardia fulfilling task force criteria for arrhythmogenic right ventricular cardiomyopathy: initial suspicion based on the 12-lead electrocardiogram. Europace. https://doi.org/10.1093/europace/euaf136

Vancouver

Hoogendoorn JC, Bosman LP, van der Heijden JF, Wilde AA, van den Berg MP, Yap SC, et al. Different underlying aetiologies in patients presenting with ventricular tachycardia fulfilling task force criteria for arrhythmogenic right ventricular cardiomyopathy: initial suspicion based on the 12-lead electrocardiogram. Europace. 2025. doi:10.1093/europace/euaf136

BibTeX
@article{Hoogendoorn2025,
  author = {Hoogendoorn, Jarieke C and Bosman, Laurens P and van der Heijden, Jeroen F and Wilde, Arthur A and van den Berg, Maarten P and Yap, Sing-Chien and van Tintelen, J Peter and Dooijes, Dennis and Te Riele, Anneline S J M and Zeppenfeld, Katja},
  title = {Different underlying aetiologies in patients presenting with ventricular tachycardia fulfilling task force criteria for arrhythmogenic right ventricular cardiomyopathy: initial suspicion based on the 12-lead electrocardiogram},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf136}
}
Kostenlos starten →